Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Change in Accured Expenses (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Change in Accured Expenses for 16 consecutive years, with -$705047.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses rose 80.72% to -$705047.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$783995.0, a 82.47% increase, with the full-year FY2024 number at -$412549.0, up 66.41% from a year prior.
  • Change in Accured Expenses was -$705047.0 for Q3 2025 at GeoVax Labs, down from -$406110.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $7.1 million in Q4 2021 to a low of -$3.7 million in Q3 2024.
  • A 5-year average of $63107.9 and a median of -$208839.0 in 2023 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 6323.45% in 2021, then crashed 440.48% in 2022.
  • GeoVax Labs' Change in Accured Expenses stood at $7.1 million in 2021, then tumbled by 128.75% to -$2.0 million in 2022, then tumbled by 74.47% to -$3.6 million in 2023, then skyrocketed by 114.01% to $499160.0 in 2024, then crashed by 241.25% to -$705047.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Change in Accured Expenses are -$705047.0 (Q3 2025), -$406110.0 (Q2 2025), and -$171998.0 (Q1 2025).